• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Microbiology - Articles and news items

BioBLU3

Eppendorf expands single-use vessel portfolio for microbial fermentation

Supplier news / 31 May 2016 / Eppendorf

Eppendorf’s BioBLU 3f Single-Use Vessels specifically address the demands of high cell density fermentation of bacteria, yeasts and fungi…

A novel approach in assessing the antimicrobial efficacy of eye drop products

A novel approach in assessing the antimicrobial efficacy of eye drop products

Issue 2 2016, Microbiology / RMMs / 4 May 2016 / Mostafa Eissa, Hikma Pharmaceuticals

The microbial contamination of medicinal products constitutes a continuous threat to the health of consumers, which may negatively impact pharmaceutical companies’ reputability. However, multidose sterile pharmaceutical products are prone to contamination either from the normal flora of the human body or from the surrounding environment, following their misuse by patients. With the absence of strict medical supervision from medical professionals, patients can infect themselves with such a contaminated product. The study described in this article provides a new prospective view on the preservative efficacy test (PET) to assess the potency of antimicrobial agent(s) in two formulae of eye drops as well as quantitatively determining the risk of recontamination by the consumer…

Cherwell introduces new Redipor® prepared media products to support customer needs

Cherwell introduces new Redipor® prepared media products to support customer needs

Supplier news / 22 March 2016 / Cherwell Laboratories

New 2016 Redipor® price list available on request…

The challenges of riskbased environmental monitoring in sterile product filling

The challenges of riskbased environmental monitoring in sterile product filling

Issue 1 2016, Microbiology / RMMs / 29 February 2016 / James L. Drinkwater, Chairman, Pharmaceutical and Healthcare Sciences Society

Completing risk assessments is an inherent part of good manufacturing practice (GMP) and risk-based environmental control and monitoring (EM) in sterile product filling within isolators and restricted access barrier systems (RABS). This article considers the challenges the pharmaceutical industry faces in characterising conventional risk assessments like failure modes and effects analysis (FMEA) for determination of risk-based EM programs, considering aspects of the filling machine, barrier separation technology, surrounding cleanroom environment, monitoring methods/systems and process operations. The requirement for process monitoring for the manufacture of sterile medicinal products is starting to be discussed in the revision of EU GMP Annex 1, so as to bring together all EM data and hence consider the process holistically…

Whitepaper: Is it essential to sequence the entire 16S rRNA gene for bacterial identification?

Whitepaper: Is it essential to sequence the entire 16S rRNA gene for bacterial identification?

Whitepapers / 1 February 2016 / Charles River

The biopharmaceutical industry, especially manufacturing facilities, needs to implement bacterial identification to avoid the occurrence of a problematic microorganism in the final product that could be harmful for the end user and detrimental to a company’s finances and reputation…

rmms

Emerging trends in microbiological diagnostics: an introduction to rapid microbiological methods

Blog / 29 January 2016 / Adewale Joseph Ogunleye, Adekunle Ajasin University, Akungba Akoko, Ondo State, Nigeria

This article explores how scientists are developing a fast, qualitative and specific technique for the detection and classification of microorganisms…

The limitations of the colony-forming unit in microbiology

The limitations of the colony-forming unit in microbiology

Issue 6 2015, Microbiology / RMMs / 6 January 2016 / Tony Cundell, Microbiological Consulting LLC

The recent revision to USP General Informational Chapter <1223> Validation of Alternative Microbiological Methods that became official on December 1, 2015 contained a section discussing the limitations of the colony-forming unit (CFU) in terms of enumerating only those microorganisms that readily grow on solid microbiological media. The section highlights its inappropriateness as a gold standard for method validation when there are many signals available other than CFUs for the detection, enumeration and identification of microorganisms in water, air, pharmaceutical ingredients and drug products…

Cherwell strengthens team with Microbiology Product Specialist appointment

Cherwell strengthens team with Microbiology Product Specialist appointment

Supplier news / 14 December 2015 / Cherwell Laboratories

Company boosts industrial microbiology expertise to enhance customer support…

Portsmouth PMU selects Cherwell for quality and service in environmental monitoring

Portsmouth PMU selects Cherwell for quality and service in environmental monitoring

Supplier news / 18 November 2015 / Cherwell Laboratories

Cherwell publishes case study discussing key considerations when purchasing an active air sampler…

Wickham Laboratories announces new microbial identification service

Wickham Laboratories announces new microbial identification service

Supplier news / 3 November 2015 / Wickham Laboratories

Introducing the MALDI Biotyper® for rapid microbial identification….

SMi Group Logo

Merial Sas, GSK, Sanofi Pasteur, Nestle Research Center will meet at the SMi’s 5th Annual Pharmaceutical Microbiology Conference in London

Supplier news / 7 September 2015 / SMi

SMi is delighted to announce that the 5th Annual Conference on Pharmaceutical Microbiology will be taking place on the 20th-21st January 2016 at the Holiday Inn Kensington Forum in London, UK…

Harshad Joshi

Cherwell appoints Harshad Joshi as new Quality Manager

Supplier news / 7 September 2015 / Cherwell Laboratories

Company maintains focus on quality to meet customer expectations…

 

Webinar: High-throughput MALDI TOF mass spectrometry for drug discoveryFIND OUT MORE
+ +